LUND, Sweden, Nov. 13, 2015 /PRNewswire/ -- BONESUPPORT(TM), an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, today announced that Lloyd Diamond, CEO of BONESUPPORT(TM), will provide a corporate overview at the Stifel 2015 Healthcare Conference in New York, NY, on November 18, 2015. The presentation will be audio-webcast live and archived for replay following the conference.
Stifel 2015 Healthcare Conference Presentation Date: Wednesday, November 18, 2015 Time: 4:30 pm Eastern Time Location: New York, NY - The New York Palace Hotel, Henry Room Webcast: http://www.veracast.com/webcasts/stifel/healthcare2015/97212649653.cfm [http://www.veracast.com/webcasts/stifel/healthcare2015/97212649653.cfm]
About BONESUPPORT(TM) BONESUPPORT(TM) is an emerging leader of injectable bone graft substitutes for orthopedics, and trauma focusing on bone infection, instrument augmentation and spinal applications. CERAMENT(TM) is an injectable, synthetic bone substitute that mimics the properties of cancellous bone, allows for controlled resorption to support future bone ingrowth and is injectable under local anesthesia for minimally invasive surgery. CERAMENT(TM)|G and CERAMENT(TM)|V are the first CE-marked injectable antibiotic eluting ceramic bone graft substitutes indicated to promote and protect bone healing in the management of osteomyelitis, (bone infections). CERAMENT's unique biologic properties deliver a consistent, pre-packed and ready-to-use formulation to facilitate optimal delivery. CERAMENT(TM)|G and CERAMENT(TM)|V are not available in the United States.
CERAMENT(TM) is a fully developed product platform that is commercially available in the U.S., Europe, SE Asia and the Middle East. CERAMENT(TM) is revolutionizing the treatment of fragility and other fractures caused by disease and trauma. Scientific research of CERAMENT(TM) spans more than eleven years. Over fifty pre-clinical, clinical and animal studies have been conducted and more than 20,000 patients have been treated with CERAMENT(TM). The company was founded in 1999 and is based in Lund, Sweden with subsidiary locations in the US and Germany. To learn more about BONESUPPORT(TM) please visit www.bonesupport.com [http://www.bonesupport.com/].
Press Inquiries: Offer Nonhoff Chief Financial Officer Offer.Nonhoff@bonesupport.com [mailto:Offer.Nonhoff@bonesupport.com] Phone +46 46 286 53 60
PR 0480-01 en
Web site: http://www.bonesupport.com/